Neonatal jaundice: Physiologic variation or pathologic process

Critical Care Nursing Clinics of North America

Volumn 16, Issue 2, 2004, Pages 257-269

  Reiser, Diana J ^a  

^a ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; AGAR; METALLOPORPHYRIN; PHENOBARBITAL;

BILE DUCT ATRESIA; BILIRUBIN BINDING; BILIRUBIN METABOLISM; BLOOD GROUP ABO INCOMPATIBILITY; BREAST FEEDING; BREAST MILK; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; ENTEROHEPATIC CIRCULATION; EXCHANGE BLOOD TRANSFUSION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; HYPOTHYROIDISM; KERNICTERUS; LABORATORY TEST; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN HEPATITIS; NEWBORN JAUNDICE; PHOTOTHERAPY; POLYCYTHEMIA; REVIEW; RHESUS INCOMPATIBILITY; SEPTICEMIA;

ANEMIA, HEMOLYTIC, CONGENITAL; BILIRUBIN; BREAST FEEDING; ERYTHROBLASTOSIS, FETAL; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; JAUNDICE, NEONATAL; PATIENT DISCHARGE; PHOTOTHERAPY;

EID: 2442589925     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2004.02.010     Document Type: Review

References (40)

1. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994;94:558-62.
2. Halamek L, Stevenson D. Neonatal jaundice and liver disease. In: Fanarof A, Martin R, editors. 6th edition. Neonatal-perinatal medicine: diseases of the fetus and infant, vol. 2. St. Louis (MO): Mosby-Year Book;1997. p. 1345- 89.
3. Brodt A, Bantz H, Daly J. Newborn readmissions. J Nurs Adm 1996;26(3):5.
4. Seidman D, Stevenson D, Zivanit E, Gale R. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics 1995;96:727-9.
5. American Academy of Pediatrics, Work Group on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 1998;100:1035-9.
6. Brown A, Johnson L. Early neonatal discharge and reemergence of kernikterus in term infants. American Academy of Pediatrics Section on Perinatal Pediatrics, Program Abstract Booklet. October 27, 1995.
7. Schwoebel A, Sakraida S. Hyperbilirubinemia: new approaches to an old problem. J Perinat Neonatal Nurs 1997;11:78-97.
8. Smith J. Hyperbilirubinemia. In: Mattson S, Smith J, editors. Core curriculum for maternal-newborn nursing. Philadelphia: W.B. Saunders; 2000. p. 705-15.
9. Frank C, Cooper S, Merenstein G. Jaundice. In: Merenstein G, Gardner S, editors. Handbook of neonatal intensive care. 4th edition. St. Louis (MO): Mosby-Year Book; 1998. p. 393-412.
10. MacMahon J, Stevenson D, Oski F. Bilirubin metabolism; physiologic jaundice; bilirubin toxicity, encephalopathy and kernicterus: unconjugated hyperbilirubinemia: management of neonatal hyperbilirubi-nemia. In: Taeusch H, Ballard R, editors. Avery's diseases of the newborn. 7th edition. Philadelphia: W.B. Saunders; 1998. p. 995-1043.
11. Sater K. Color me yellow: caring for an infant with hyperbilirubinemia. J Intravenous Nurs. 18:1995;317-325
12. Shaw K. Assessment and management of hematologic dysfunction. In: Kenner C, Lott J, Flandermeyer A, editors. Comprehensive neonatal nursing: a physiologic perspective. 2nd edition. Philadelphia: W.B. Saunders; 1998. p. 520-63.
13. Dixit R, Gartner L. The jaundiced newborn: minimizing the risks. Patient Care 2000;34(2):45-69.
14. Lawrence RA, Lawrence RM. Breastfeeding: a guide for the medical profession. 5th edition. St. Louis (MO): Mosby-Year Book; 1999.
15. Banks J, Montgomery D, Coody D, Yetman R. Hyperbilirubinemia in the term newborn. J Pediatrc Healthcare 1996;10:228-30.
16. Yetman R, Parks D, Huseby B, Mistry K, Garcia J. Rebound bilirubin levels in infants receiving phototherapy. J Pediatr 1998;133:705-7.
17. Tan K. Decreased response to phototherapy for neonatal jaundice in breast-fed infants. Arch Pediatr Adolesc Med 1998;152:1187-90.
18. MacDonald M. Hidden risks: early discharge and bilirubin toxicity due to glucos-6-phosphate dehydrogenase deficiency. Pediatrics 1995;96:734-8.
19. Washington E, Ector W, Abboud M, Ohning B, Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J 1995;88:776-9.
20. American Academy of Pediatrics, Committee on Genetics. Glucose-6-phosphate dehydrogenase (G6PD) deficiency, newborn screening fact sheets (RE9632). Pediatrics 1996;98:473-501.
21. Penn A, Enzman D, Hahn J, Stevenson D. Kernicterus in the full term infant. Pediatrics 1994;93:1003-6.
22. Johnson L. Hyperbilirubinemia in the term infant: when to worry, when to treat. N Y State J Med 1991;91:483-9.
23. Martich-Kriss V, Kollias S, Ball W. MR findings in kernicterus. AJNR Am J Neuroradiol 1999;16:819-21.
24. Melton K, Akinbi H. Neonatal jaundice: strategies to reduce bilirubin-induced complications. Postgrad Med 1999;106:167-78.
25. Stevenson D, Vreman H. Carbon monoxide and bilirubin production in neonates. Pediatrics 1997;100:252-4.
26. Brown A, Damus K, Kim M, King K, Harper R, Campbell D, et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. J Perinat Med 1999;27:263-75.
27. Lasker M, Holzman I. Neonatal jaundice: when to treat, when to watch and wait. Postgrad Med 1996;99:187-98.
28. Maisels M, Newman T. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics 1999;103:493-5.
29. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 1995;96:730-3.
30. Cottrell B, Todd N. Home care concerns for the normal newborn. Home Care Provid 1998;3:293-7.
31. Bhutani V, Johnson L, Sivieri E. Ability of a pre-discharge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term infants. Pediatrics 1999;103:6-14.
32. Stevenson DK, Vreman HJ. Carbon monoxide and bilirubin production in neonates. Pediatrics 1997;100:252-4.
33. Simpson K, Creehan P. Hyperbilirubinemia. In: Simpson K, Creehan P, editors. Perinatal nursing. Philadelphia: Lippincott-Raven; 1996. p. 362-5.
34. Sarici S, Alpay F, Unay B, Ozcan O, Gokcay E. Double versus single phototherapy in term newborns with significant hyperbilirubinemia. J Trop Pediatr 2000;46:36-9.
35. Kang J, Shankaran S. Double phototherapy with high irradiance compared with single phototherapy in neonates with hyperbilirubinemia. Am J Perinatol 1995;12:178-80.
36. Garg A, Prasad R, Hifzi I. A controlled trial of highintensity double-surface phototherapy on a fluid bed versus conventional phototherapy in neonatal jaundice. Pediatrics 1995;95:914-6.
37. Hamelin K, Seshia M. Home phototherapy for uncomplicated neonatal jaundice. Can Nurse 1998;94:39-40.
38. Kappas A, Drummond G, Henschke C, Valaes T. Direct comparison of Sn-Mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term infants. Pediatrics 1995;95:468-74.
39. Valaes T, Drummond G, Kappas S. Control of hyperbilirubinemia in flucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production. Pediatrics 1998;101:1-5.
40. Seidman DS, Stevenson DK, Ergaz Z, Gale R. Hospital readmission due to neonatal hyperbilirubinemia. Pediatrics 1995;96:727-9.